Highmark to reduce payments for some oncology-related services

Pittsburgh Post-Gazette, February 27, 2014
Highmark will no longer accept price markups on some oncology-related services beginning April 1, the Pittsburgh insurer announced Wednesday, a move that health provider giant UPMC promptly labeled "an egregious contract violation." What's at stake is some $200 million in annual markups for cancer treatments from a variety of providers -- including UPMC -- double the amount billed from just three years ago, said pediatric cardiologist Donald R. Fischer, chief medical officer for Highmark Blue Cross Blue Shield. "It was growing uncontrollably," he said, "so we decided to fix this."

MOST POPULAR

SPONSORED REPORTS
SPONSORED HEADLINES

SIGN UP

FREE e-Newsletters Join the Council Subscribe to HL magazine

SPONSORSHIP & ADVERTISING

100 Winners Circle Suite 300
Brentwood, TN 37027

800-727-5257

About | Advertise | Terms of Use | Privacy Policy | Reprints/Permissions | Contact
© HealthLeaders Media 2015 a division of BLR All rights reserved.